Complex visual hallucinations and hallucinosis occurs frequently (5-40%) in patients with Parkinson’s disease, especially after many years of treatment with dopaminergic drugs. Duration and severity of the disease, the presence of depression, sleep problems and cognitive decline are predisposing factors.
Visual hallucination (frequently blurry) arrive with the open eyes, are usually brief (few seconds) and move for short periods. They consists of object but more often of animals or people, unknown or known by the patient. Sometimes, the hallucination is a dead relative. Many patient try to interact with the hallucinations although most of them appear to know that it is just an illusion. Thus, insight is variably impaired. The semiology is quite similar to hallucinations, which occur with the Charles-Bonnet Syndrome (hallucinosis or visual hallucinations in patients with blindness or severe reduction of visual acuity).
Antiparkinsonian agents (especially dopamine-agonists), are probably the most powerful trigger factor in patients with Parkinson. Several mechanisms should interact with dopaminergic stimulation for the occurrence of hallucinations.
These mechanisms are related to the excitability or to release phenomena in higher visual center (secondary visual associative areas), to defective central or peripheral visual processing and to brainstem modulation of thalamocortical projections. Lewy body deposits in Parkinson’s disease and Lewy Body Disease are prominent in brainstem and primary and secondary visual areas.
However, the phenomenon is quite complex and still mysterious as sensory, cognitive, emotional, attentional factors intervene together with default of reality-checking processes.
Dopaminergic drugs should be carefully assessed to reduce hallucinations. Comorbidities should be treated. Atypical neuroleptics (Clozapine more than Quetiapine) and Rivastigmine are drugs that could be helpful. The effects of behavioral and cognitive interventions have not been adequately studied.
-
Articles récents
Archives
- octobre 2019
- septembre 2019
- août 2019
- juillet 2019
- mai 2019
- avril 2019
- mars 2019
- février 2019
- octobre 2018
- septembre 2018
- juillet 2018
- juin 2018
- mai 2018
- avril 2018
- mars 2018
- février 2018
- août 2017
- juillet 2017
- avril 2016
- février 2016
- décembre 2015
- novembre 2015
- août 2015
- juillet 2015
- mai 2015
- mars 2015
- février 2015
- novembre 2014
- octobre 2014
- septembre 2014
- août 2014
- juillet 2014
- juin 2014
- mai 2014
- avril 2014
- mars 2014
- février 2014
- janvier 2014
- décembre 2013
Subscribe to Blog via Email
Catégories
- Alcohol-related syndromes
- Alzheimer
- Aphasia
- Apraxia
- Cerebrovascular diseases
- Cognition and Behavior
- Cranial Nerves
- Delirium
- Dyscalculia
- Epilepsy
- Headache
- Lewy Body Disease
- Memory
- Movement disorders
- Multiple Sclerosis
- Neuro-ORL
- Neurologic mysteries
- neuromodulation
- Neurorehabilitation
- Neurotoxicology
- Pain syndromes
- Parkinson Disease
- Peripheral Nervous System
- Progressive Supranuclear Palsy
- Psychiatry
- rTMS
- Sleep
- Spine
- Stroke
- Uncategorized
- Unilateral Spatial Neglect
- visual disorders